Jamie Christensen, SVP, Chief Science Officer at Mirati Therapeutics, Inc. (MRTX), sold 4,000 shares at $14.00 ($56K) on 2017-10-04, disclosed to the SEC on 2017-10-06.
Open-market sale of $56k MRTX by SVP, Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRTX | SELL | 2023-12-19 | $275K | — | Filing → |
| MRTX | SELL | 2023-09-12 | $170K | — | Filing → |
| MRTX | SELL | 2023-05-24 | $28K | — | Filing → |